skip to content
Home

Department of Oncology

 

News Subscribe to News

Read more at: Halving treatment for HER2+ early breast cancer patients

Halving treatment for HER2+ early breast cancer patients

6 August 2019

The PERSEPHONE trial, led by Professor Helena Earl (Oncology and CRUK Cambridge Centre), recruited over 4,000 women with HER2 positive early breast cancer to establish the outcomes of shortening the duration of treatment. This £2.6 million study funded by the (National Institute for Health Research (NIHR) with...

Read more at: Clinical trial offers experimental cancer treatment to patients with the same genetic mutations

Clinical trial offers experimental cancer treatment to patients with the same genetic mutations

12 March 2019

A new type of experimental trial, the Basket of Baskets trial has just launched in Cambridge to treat patients with different types of cancer with the same targeted therapy. The trial uses a common molecular profiling platform to allocate patients to targeted therapies, based on the genetic features of their individual...

Read more at: Early diagnosis prize

Early diagnosis prize

11 February 2019

Professor Rebecca Fitzgerald receives the prestigious 'Jane Wardle Prevention and Early Diagnosis' prize from Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK/CEO of Cancer Research Technology. This prestigious prize recognises individuals who have produced world-leading research in the...

Read more at: Clinical trial launches to develop breath test for multiple cancers

Clinical trial launches to develop breath test for multiple cancers

11 February 2019

Professor Rebecca Fitzgerald , Department of Oncology, MRC Cancer Unit and co-lead of the CRUK Cambridge Centre Early Detection Programme is leading a new clinical trial at Addenbrooke’s Hospital to develop a breath test that could indicate the presence of multiple cancer types at an early stage. This is the first test of...

Read more at: Mapping oesophageal cancer genes leads to new drug targets

Mapping oesophageal cancer genes leads to new drug targets

11 February 2019

Professor Rebecca Fitzgerald , Department of Oncology, MRC Cancer Unit and co-lead of the CRUK Cambridge Centre Early Detection Programme is the lead researcher of a recent study that identified mutations responsible for oesophageal adenocarcinoma (OAC), using a combination of whole genome sequencing and whole exome...

Read more at: Professor Anna Philpott receives the '2018 Anne McLaren Outstanding Women in Developmental Biology Award'

Professor Anna Philpott receives the '2018 Anne McLaren Outstanding Women in Developmental Biology Award'

23 October 2018

Congratulations to Professor Anna Philpott who has received the ‘2018 Anne McLaren Award for Outstanding Women in Developmental Biology' from the International Society of Differentiation (ISD). Professor Philpott accepted her award at the CamBio2018 Conference, a major biennial conference organised jointly by the ISD and...

Read more at: Personalised Breast Cancer DNA ‘barcoding’ Programme to be rolled out

Personalised Breast Cancer DNA ‘barcoding’ Programme to be rolled out

14 August 2018

The pioneering Cambridge based Personalised Breast Cancer Programme (PBCP), led by the Department of Oncology's Professor Carlos Caldas , with Dr Jean Abraham co-leading the study in the clinic, was set up to both advance research and to benefit patients currently undergoing treatment. Breast cancer is not one disease, but...

Read more at: A versatile drug delivery system targeting senescent cells

A versatile drug delivery system targeting senescent cells

3 August 2018

Dr Daniel Munoz-Espin, in collaboration with Dr Manuel Serrano (Institute for Research in Biomedicine, IRB, Barcelona) and Prof Ramón Martínez-Máñez (Polytechnic University of Valencia), h as recently published a study in EMBOpress exploring drug delivery into senescent cells. Senescent cells accumulate in multiple age‐...

Read more at: Harrassment, Bullying and Sexual Misconduct - Breaking the Silence

Harrassment, Bullying and Sexual Misconduct - Breaking the Silence

12 January 2018

Breaking the Silence is a University of Cambridge initiative to address behaviour that amounts to harassment, bullying or sexual misconduct within the University community. Such behaviour is not tolerated and the University has developed a website offering information for students and staff about the support and reporting...

Read more at: Oncology leaders in top 50 female innovators in UK healthcare business

Oncology leaders in top 50 female innovators in UK healthcare business

12 January 2018

Jean Abraham and Rebecca Fitzgerald are named in a new report unveiling 50 female leaders in healthcare business in the UK. Produced by BioBeat, 5 0 Movers and Shakers in BioBusiness 2017 emphasises how diversity of thinking is critical to the success of the sector in the UK. The report also celebrates how women are...

Contact us

 

Terms and conditions

Accessibility

Sitemap

Study at Cambridge

About the University

Research at Cambridge